A 20-year-old girl was brought by her mother, herself a medical doctor, with a long history of recurrent severe infections beginning in early childhood.
She developed middle lobe collapse in childhood, for which a lobectomy was performed, yet she continued to suffer from recurrent respiratory infections thereafter.
Over the years, the frequency and severity of infections progressively increased; initially occurring every three to six months, then becoming more frequent, and now recurring almost every ten days.
In the past year, she was treated for multidrug-resistant tuberculosis, and her infectious history also includes pulmonary aspergillosis, staphylococcal infections, and Moraxella infections, involving predominantly the respiratory tract.
Despite extensive investigations over the years and management at multiple levels of care, no unifying diagnosis has yet been established, raising strong concern for an underlying, previously unrecognized primary immunodeficiency disorder.
What is Chronic Granulomatous Disease (CGD):
CGD is a rare but life-threatening primary immunodeficiency caused by a defect in the ability of neutrophils to kill certain bacteria and fungi.
Although traditionally considered a childhood disease, many patients—especially females—present in adolescence or adulthood, often after years of recurrent infections.
CGD should be strongly suspected in any young patient with:
- Recurrent lung infections since childhood
- Severe or unusual organisms (e.g., Aspergillus, Staphylococcus, TB)
- Normal immunoglobulin levels
- Poor response to standard treatments
Pathophysiology (What Goes Wrong in CGD?)
In CGD, neutrophils lack a functioning NADPH oxidase enzyme, which is required to produce reactive oxygen species (oxidative burst). Without this burst:
- Phagocytes can ingest pathogens
- ❌ But cannot kill catalase-positive organisms
This leads to:
- Recurrent infections
- Granuloma formation
- Persistent inflammation
Genetics
- X-linked CGD (most common)
- Autosomal recessive CGD
- Females may be symptomatic carriers due to lyonization
Common Organisms Seen in CGD:
CGD patients are particularly susceptible to catalase-positive organisms, including:
- Staphylococcus aureus
- Aspergillus species (hallmark infection)
- Serratia marcescens
- Burkholderia cepacia
- Nocardia
- Mycobacterium tuberculosis and atypical mycobacteria
📌 Aspergillus pneumonia in a young person with normal Ig levels is CGD until proven otherwise.
Clinical Features of CGD:
Recurrent Infections
- Pneumonia
- Lung abscesses
- Skin abscesses
- Osteomyelitis
- Lymphadenitis
Pulmonary Complications of CGD:
- Recurrent pneumonias
- Bronchiectasis
- Cavitary lesions
ENT Involvement:
- Recurrent otitis media
- Chronic sinusitis
- Hearing loss (secondary to chronic ear disease)
How to Diagnose CGD:
🔑 Gold Standard Test
Dihydrorhodamine (DHR) Flow Cytometry
- Measures neutrophil oxidative burst
- Preferred over the older NBT test
DHR Result Patterns:
|
Pattern |
Interpretation |
|
Absent oxidative burst |
CGD confirmed |
|
Mosaic pattern |
Female carrier with clinical disease |
|
Normal burst |
CGD unlikely |
📌 Routine flow cytometry (CD3/CD4/CD8/CD19) does NOT diagnose CGD.
Additional Investigations
- CBC with differential
- ESR / CRP
- HRCT chest (bronchiectasis, cavities)
- Sputum culture (bacterial, fungal, AFB)
- TB GeneXpert and culture
- ENT assessment + audiometry
- Genetic testing (if available)
Differential Diagnosis: How to Differentiate CGD from Similar Conditions:
|
Condition |
Key Difference |
|
CVID |
Low IgG/IgA, responds to IVIG |
|
Primary ciliary dyskinesia (PCD) |
ENT disease predominant, normal DHR |
|
IL-12/IFN-γ defect (MSMD) |
Severe TB but less fungal disease |
|
HIV |
Acquired, CD4 decline |
|
Post-TB bronchiectasis |
Structural disease without immune defect |
📌 Normal immunoglobulin levels strongly argue against CVID.
Management of CGD
1️⃣ Infection Prevention (Cornerstone of Treatment)
Antibacterial Prophylaxis
- Trimethoprim–Sulfamethoxazole (TMP-SMX)
- Reduces serious infections by >70%
Antifungal Prophylaxis
- Itraconazole (mandatory if prior Aspergillus)
- Monitor liver function
Interferon-Gamma (IFN-γ)
(If available)
- Reduces severe infections
- SC injections 3 times weekly
2️⃣ Management of Acute Infections
⚠️ Any fever in CGD is a medical emergency
- Immediate cultures
- Early broad-spectrum IV antibiotics
- Consider antifungal therapy if pulmonary symptoms
3️⃣ TB and Mycobacterial Disease
- Strict adherence to MDR-TB protocols
- Longer treatment courses often required
- Close infectious disease supervision
4️⃣ Pulmonary & ENT Care
- Regular chest physiotherapy
- Early treatment of exacerbations
- ENT follow-up for hearing loss
- Audiometry and hearing rehabilitation if needed
Vaccination Guidelines
✅ Allowed (Non-Live Vaccines)
- Influenza
- Pneumococcal
- COVID-19
- Hepatitis B
❌ Contraindicated (Live Vaccines)
- BCG
- Oral polio
- MMR
- Varicella
Lifestyle & Preventive Advice
Patients should avoid:
- Gardening and soil exposure
- Compost, mulch
- Construction sites
- Mold-rich environments
Seek urgent care for:
- Fever
- Chest pain
- Persistent cough
- Skin swelling or abscess
Definitive Treatment: Hematopoietic Stem Cell Transplant (HSCT)
🔴 HSCT is the only curative treatment for CGD
Best considered when:
- Severe infections
- Aspergillus disease
- MDR-TB
- Young age
Early referral improves outcomes.
Family Screening & Genetic Counseling
- Screen siblings
- Test the mother for carrier status
- Counsel regarding future pregnancies
Key Take-Home Messages
- Normal immunoglobulins do not exclude immunodeficiency
- Aspergillus infection in young patients is a red flag
- DHR flow cytometry is the diagnostic test of choice
- Early prophylaxis saves lives
- HSCT offers a cure in selected patients
Conclusion:
Chronic Granulomatous Disease is often missed for years, leading to preventable complications. Awareness, early diagnosis, and appropriate long-term management can dramatically improve survival and quality of life.